- Zacks Small Cap Research•2 days ago
CytoSorbents (CTSO) has had a busy last couple of months leading up to the annual JP Morgan, Biotech Showcase and Medtech Showcase conferences which were held earlier this week in San Francisco and where management took some time to talk to us. Just prior to the company’s presentation at the Biotech Showcase they announced an expanded agreement with Fresenius and preannounced expected Q4 and FY2016 product sales. Per the January 10th preannouncement, CTSO expects Q4 product sales of ~$2.6M, implying sequential and yoy growth of approximately 21% and 74%, respectively, and marking the sixth straight quarter of record product sales. Product sales of $2.6M is also almost 16% higher than what we had forecast ($2.2M).
- TheStreet.com•21 days ago
Abbott can now proceed with its $25 billion buy of St. Jude Medical.
- The Wall Street Journal•2 months ago
Abbott Laboratories and St. Jude said they would sell certain businesses to Terumo for about $1.1 billion as the two American companies march toward completing their merger.
TRUMF : Summary for TERUMO CORP NPV - Yahoo Finance
Terumo Corporation (TRUMF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 10:19AM EST
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||37.50|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|